Advertisement

Innovation

Generative artificial intelligence, although a new technology, is already showing signs of potential in the healthcare industry; for example, the technology is being used for ambient documentation and is helping lower drug research and development costs, CB Insights reported May…

Biopharmaceutical research and commercialization company Syneos Health is set to be acquired by Elliott Investment Management, Patient Square Capital and Veritas Capital for $43 per share, or $7.1 billion.

Advertisement
Advertisement